Clinical significance of cancer antigen, CA 15.3 in breast cancer.
Breast cancer is the leading type of cancer in women. It is commonly accepted that the earlier the detection of the disease, the better the prognosis. Therefore, the present study was undertaken to evaluate the clinical significance of tumour marker CA 15-3 along with Carcinoembryonic antigen (CEA) in India women population. Tumour marker CA 15-3 concentrations reflected the tumour burden in a better way than CEA. However, the use of CEA as an additional conventional marker improved the Clinical efficiency of the marker CA 15-3.
Biochemistry Department, Tata Memorial Hospital, Annexe Bld., 6th Floor, Dr E Borges Marg, Parel, Mumbai-400 012.
S
S
Muthuswamy
A S
AS
Raste
D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood*; D001941:Breast Diseases / Q000175:diagnosis; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000276:immunology*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D016022:Case-Control Studies; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007194:India; D018396:Mucin-1 / Q000097:blood*
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D018396:Mucin-1